Congenital fetal heart block: A potential therapeutic role for intravenous immunoglobulin

Obstetrics and Gynecology

Volumn 117, Issue 1, 2011, Pages 177-

  Brucato, Antonio ^a   Ramoni, Véronique ^a   Gerosa, Maria ^b   Pisoni, Maria Pia ^c  

^a OSPEDALI RIUNITI   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ATRIOVENTRICULAR BLOCK; AUTOPSY; CONGENITAL HEART BLOCK; CONNECTIVE TISSUE DISEASE; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; DRUG USE; FETUS DEATH; FETUS DISEASE; FETUS HEART RATE; GESTATION PERIOD; HUMAN; LETTER; MYOCARDITIS; PRIORITY JOURNAL; SINGLE DRUG DOSE; TREATMENT DURATION;

FEMALE; FETAL DISEASES; HEART BLOCK; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PREGNANCY; PREGNANCY COMPLICATIONS; SJOGREN'S SYNDROME;

EID: 78650783608     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3182042972     Document Type: Letter

References (4)

1. Rybo G. Tranexamic acid therapy: effective treatment in heavy menstrual bleeding. Clinical update on safety. Ther Adv 1991;4:1-8.
2. Lippi G, Franchini M. Pathogenesis of venous thromboembolism: when the cup runneth over. Semin Thromb Hemost 2008;34:747-61.
3. Grimes D, Schulz KF. Surrogate end points in clinical research: hazardous to your health. Obstet Gynecol 2005; 105:1114-8.
4. Lee C, Kadir R, Kouides P. Inherited bleeding disorders in women. West Sussex (UK): Wiley-Blackwell; 2008.